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Identification of Responsive Cells in the
Developing Somite Supports a Role for
b-Catenin-Dependent Wnt Signaling in
Maintaining the DMLMyogenic Progenitor Pool
Ian Brauner,1 Douglas B. Spicer,2 Catherine E. Krull,3 and Judith M. Venuti1*
Somitic b-catenin is involved in both maintaining a stem cell population and controlling myogenic differ-
entiation. It is unclear how b-catenin-dependent Wnt signaling accomplishes these disparate roles. The
present study shows that only dorsal cells in the early somite respond to b-catenin-dependent Wnt signal-
ing and as the somites compartmentalize to form the dermomyotome and myotome, responding cells are
detected primarily in the dorsomedial lip (DML). Forced activation of Wnt target genes in DML cells pre-
vents their progeny from entering the myotome, while blocking activation allows myotomal entry. This
suggests a role for b-catenin-dependent/Wnt signaling in maintaining progenitor cells in the DML and
that if b-catenin-dependent/Wnt signaling is required to induce myogenesis, the response is transitory
and rapidly down-regulated. Developmental Dynamics 239:222–236, 2010. VC 2009 Wiley-Liss, Inc.
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INTRODUCTION
All skeletal muscle in the vertebrate
trunk is derived from somites, the
segmental structures that form from
the paraxial mesoderm in a rostral to
caudal progression during develop-
ment. As new somites form caudally,
the more rostral somites undergo a
process of compartmentalization.
Newly formed somites are epithelial
balls, and as development proceeds,
cells migrate away from the ventral
region to form the sclerotome; the
remaining dorsal cells form an epithe-
lial layer, the dermomyotome. Skele-
tal muscle precursors arise primarily
from the dermomyotome to form the
back as well as the body wall and
limb muscles (for a recent review, see
Bryson-Richardson and Currie, 2008).
Skeletal myogenesis is initiated in
somitic cells as they delaminate from
the lips of the dermomyotome. The
dorsomedial lip (DML) represents the
initial site of primary myotome induc-
tion and is the site of involution of
myotomal precursors of the epaxial
muscles. During primary myotome
formation, the DML is an important
source of epaxial muscle precursors
(Denetclaw et al., 1997; Ordahl et al.,
2001); later, mitotically competent
muscle precursors invade the myoto-
mal compartment of the somite from
the central domain of the dermomyo-
tome and contribute cells to the myo-
tome (Gros et al., 2004, 2005; Ben-
Yair and Kalcheim, 2005; Kassar-
Duchossoy et al., 2005; Relaix et al.,
2005).
A complex array of signals emanat-
ing from surrounding tissues has
been shown to influence primary myo-
genesis and somite patterning. For
example, ablation of dorsal tissues,
(dorsal neural tube and ectoderm)
results in defective dermomyotome
development, whereas ablation of
ventral tissues (notochord and floor
plate) negatively affects sclerotome
formation (Brand-Saberi et al., 1993;
Dietrich et al., 1997). When epithelial
somites are cultured without neigh-
boring tissues, somite patterning and
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differentiation of muscle and cartilage
does not occur (Kenny-Mobbs and
Thorogood, 1987; Buffinger and
Stockdale, 1994; Munsterberg and
Lassar, 1995; Stern and Hauschka,
1995). Notochord and neural tube–
derived signals are thought to guide
myogenic differentiation in the first
myotomal cells and induce epaxial
myogenesis (Ordahl and Le Douarin,
1992; Buffinger and Stockdale, 1995;
Munsterberg and Lassar, 1995; Stern
and Hauschka 1995; Pownall et al.,
1996; Spence et al., 1996; Dietrich
et al., 1997). Wnt3a, Wnt1, and Wnt6
all mimic the effect of the dorsal neu-
ral tube and surface ectoderm, sug-
gesting that these Wnt ligands regu-
late myogenesis in the primary
myotome (reviewed in Geetha-Loga-
nathan et al., 2008).
Numerous studies have implicated
signaling through the canonical Wnt
pathway in the activation and main-
tenance of myogenesis both in vivo
and in vitro. Wnts initially were
shown to be required for induction of
myogenesis in somite explants in co-
culture experiments (Stern and
Hauschka, 1995; Munsterberg et al.,
1995; Fan et al., 1997; Reshef et al.,
1998). Similarly, Wnt signaling, act-
ing via b-catenin, was shown to be
necessary and sufficient for skeletal
myogenesis in P19 cells (Ridgeway
et al., 2000; Petropoulus and Sker-
jenic, 2002) and to activate myogene-
sis in adult myogenic stem cells (Pole-
sskaya et al., 2003). Furthermore,
mice null for the neural tube–derived
Wnts 1 and 3a (Ikeya and Takada,
1998) and mice treated with the Wnt
antagonist Frzb1 display myotomal
defects (Borello et al., 1999). These
data all suggest a crucial role for sig-
naling through the canonical Wnt
pathway in myogenic induction. This
is further supported by the localized
expression of transcripts of compo-
nents of the canonical Wnt pathway
in the dorsomedial-most region of the
somite where the first myogenic cells
are specified (Schmidt et al., 2000;
Cauthen et al., 2001).
Wnts are thought to induce myo-
genesis in the primary myotome
through the upregulation of b-catenin
(Schmidt et al., 2000), the key media-
tor of signaling through the canonical
Wnt pathway (Logan and Nusse,
2004). Transcripts of the Wnt receptor
Frizzled 1 (Fz1), b-catenin, and the
nuclear partner of b-catenin, Lef1, are
all expressed during somitogenesis
with Lef1 and b-catenin transcripts
restricted to the developing myotome
at later stages (Schmidt et al., 2000).
Fz2 and Fz7 are also expressed in epi-
thelial somites and in the dermomyo-
tome (Linker et al., 2003).
Although signaling through the ca-
nonical Wnt pathway participates in
the patterning of dorsal structures
and induction of myogenesis in the
somite, the cellular processes that are
regulated by b-catenin-dependent
Wnt signaling are not well under-
stood. This is compounded by conflict-
ing reports concerning the activation
of myogenic genes and the role of
Wnts in the somite. For example, it
has been proposed that induction of
myogenesis in the somite is through a
b-catenin-independent Wnt pathway
requiring PKA and CREB (Chen
et al., 2005). Similarly, a proliferative
role for signaling through the canoni-
cal Wnt-pathway via Wnt3a in the
dermomyotome has been demon-
strated (Galli et al., 2004), but it is
unclear precisely which cells are
responding and how they respond.
While Wnt1 and Wnt3a have been
shown to preferentially activate Myf5,
and Wnts6 and 7a preferentially acti-
vate MyoD (Tajbakhsh et al., 1998;
Cossu and Borello, 1999), Wnt signal-
ing directly regulates Myf5 expres-
sion through direct binding of TCF/
Lefs and b-catenin to its enhancer
(Borello et al., 2006) but MyoD is
thought to be activated through
a b-catenin-independent mechanism
(Brunelli et al., 2007). This implies
that signaling through the non-canon-
ical, b-catenin-independent, Wnt
pathway also has a role in the induc-
tion of myogenesis. Further compli-
cating the role of Wnts in myogenesis
is the recent finding that b-catenin,
but not TCF/Lefs, is required for mus-
cle differentiation and that MyoD
interacts directly with b-catenin
and that b-catenin/MyoD complexes,
instead of the b-catenin/TCF complex,
are involved in Wnt-mediated regula-
tion of muscle differentiation (Kim
et al., 2008).
Since b-catenin is a multifunctional
protein, with a role in cell adhesion as
well as Wnt signaling, transcript
expression is not indicative of where
b-catenin/TCF functions to activate
Wnt target genes. However, b-catenin
observed in the nucleus (Batlle et al.,
2002) and the activation of a Wnt re-
porter (Dorsky et al., 2002) can be
used to identify and define cells that
are responding to signaling through
the canonical Wnt pathway in the
developing somite. To begin to deter-
mine which cells of the somite respond
to signaling through the canonical
Wnt pathway, we used both immuno-
histochemistry to determine where b-
catenin is nuclearized and in ovo elec-
troporation of the reporter, TOPGFP,
to identify where in the developing
somite b-catenin/TCF/Lefs activate
Wnt target gene transcription.
We found that as the somite pro-
gresses through compartmentaliza-
tion, the cells responding to b-catenin/
Wnt signaling are present in specific
regions. In both the early somite,
prior to myotome formation (somite
IV–VI), and late somite, after myo-
tome formation (somite X and older),
Wnt-responding cells are restricted to
the dorsal Pax7-positive domain of
the somite. Wnt-responsive cells were
not found in either the myotome or
the sclerotome. Furthermore, cells
expressing an activated form of TCF
were restricted from entering the
myotome, suggesting that b-catenin/
Wnt signaling maintains the myo-
genic progenitor population in the
DML, but must be ‘‘turned off ’’ for
myogenic differentiation to proceed.
RESULTS
Nuclear b-Catenin
Localization in Somitic Cells
We first examined somites at different
developmental stages for nuclear
localization of b-catenin to determine
where and when in the somite cells
are responding to signaling through
the canonical Wnt pathway. Because
b-catenin degradation is blocked upon
the receipt of a Wnt signal and b-cate-
nin subsequently enters the nucleus,
nuclear localization of b-catenin can
be used to identify cells that are likely
to be responding to signaling through
the canonical Wnt pathway. We exam-
ined 5-lm transverse sections of
chicken embryos using immunocyto-
chemistry and antibody against b-cat-
enin, coupled with propidium iodide













nuclear staining. Since propidium
iodide stains nuclei red, antigen
detection employed a secondary anti-
body that fluoresced green, and in
this way, co-labeled nuclei would
appear yellow. Somites were analyzed
at two stages: early somites (stage
IV–VI; Fig. 1 A) prior to myotome for-
mation and later somites (stages VII–
X; Fig.1 G) that have formed a myo-
tome. These are the same somite
stages as those examined in later elec-
troporation experiments.
In early somites, there was a dis-
tinct difference in Wnt signaling
between dorsal and ventral cells.
Intense staining for nuclear b-catenin,
indicated by yellow nuclei due to co-
localization of b-catenin (green) and
the nuclear signal (red), was observed
in the dorsal epithelial cells of the pre-
sumptive dermomyotome (Fig.1B, C,
E). Strong membrane-associated b-
catenin staining was also observed
along the apical surfaces of these cells.
In contrast, no appreciable b-catenin
staining was observed in the nuclei of
ventral cells in the presumptive scle-
rotome, which appear red (Fig. 1D).
In older somites, high levels of nu-
clear b-catenin were observed in cells
restricted to the dorsomedial lip
(DML, Fig. 1H). Fewer cells with
b-catenin nuclear staining were
observed in other regions of the dermo-
myotome (Fig. 1I). Most importantly,
there was no nuclear b-catenin stain-
ing of cells in the myotome. Unlike the
cells of the DML, which have yellow
nuclei (Fig. 1H), the nuclei of the myo-
tomal cells appear red despite high
levels of membrane-bound b-catenin
(Fig. 1J) and close proximity to the
dorsal neural tube, a known source of
Wnt signals. This suggests a lack of
response to b-catenin-mediated Wnt
signaling in the myotomal cells. That
nuclear b-catenin was most clearly
observed in the cells of the DML is
consistent with data showing that Wnt
1 and Wnt 3a double knockout mice
lack a DML (Ikeya and Takada, 1998).




To further investigate which cells in
the somite respond to b(-catenin/Wnt
signaling, we used the Wnt reporter
TOPGFP (Dorsky et al., 2002), where
the expression of a destabilized GFP
protein with a half-life of approxi-
mately 12 hr is dependent upon reiter-
ated TCF/LEF1 binding elements.
Detection of GFP expression, to a first
approximation, therefore reflects cur-
rent activation of the promoter by b-
catenin-mediated Wnt signaling or
activation in the cell’s recent history.
In ovo electroporation was used to
deliver either TOPGFP or the control
plasmid pCAX/GFP, which constitu-
tively expresses GFP, to cells in
somites II–IV of HH stage-13–14
embryos. Initially, we examined differ-
ences in the b-catenin-mediated Wnt
responsiveness of dorsal versus ventral
cells, and examined somites 6 hr post-
electroporation. Pax7 expression was
used to identify dorsal somitic cells.
These early somites had compartmen-
talized into dorsal and ventral halves
but had not yet formed a myotome.
When TOPGFP was directed
towards cells in the dorsal half of the
somite, GFP-positive cells were
detected in all electroporations (Fig.
2B–D) and GFP expression was
detected only in cells that co-labeled
for Pax7. In contrast, when TOPGFP
was directed to cells in the ventral
half of the somite, GFP expression
was not observed in the Pax7-nega-
tive, ventral cells (Fig. 2E, F). Occa-
sionally, however, GFP-expressing
cells were observed when ventral cells
were electroporated, but these cells
always co-labeled with Pax7. These
results are consistent with our data
demonstrating that nuclear b-catenin
staining is observed in the dorsal but
not in the ventral half of the early
somite. As observed here and by
Fig. 1. Nuclear b-catenin is restricted to cells in the dorsal half of early somites and is found in cells in the dorsomedial lip and dermomytome,
but not in the myotome, of later (compartmentalized) somites. b-catenin nuclear localization was determined by co-labeling sections with the nu-
clear dye propidium iodide (red) and anti-b-catenin antibody (green). Wherever b-catenin and the nuclear stain co-localize, cells show distinct yel-
low nuclei (arrow in B). A: In the early somite (stage IV–VI), distinct membrane-associated b-catenin staining was observed along the apical
surfaces of dorsal cells, which will form the dermomyotome (DMT; asterisks in B, C, E). Co-localization of the nuclear stain and anti-b-catenin is
observed in the dorsal cells (B, C, E). In contrast, sclerotomal cells (SC; D) do not show pronounced b-catenin staining of any kind. In later
somites that have formed a DMT and a myotome (MYO; G–I), nuclear b-catenin is detected in cells of the dorsomedial lip (DML) and to a lesser
extent in the cells of the DMT. b-catenin staining is also pronounced in the membranes of the myotomal cells but is not detected in myotomal cell
nuclei (J; arrowhead). This indicates that the nuclear b-catenin we observe is not a consequence of high levels of membrane bound b-catenin in
the somitic cells. Sections of comparable somites (early somite, F; later somite, K) stained with nuclear stain and secondary antibody alone never
demonstrate yellow nuclei.
Fig. 2. Detection of canonical Wnt pathway responsive cells in early somites using a TOPGFP reporter. DNA encoding TOPGFP (A–F) or GFP
under the direction of the chicken b-actin promoter (pCAX/GFP) was electroporated into early somites (stage IV–VI) and somites examined later
for GFP positive cells (G, H). Sections were also labeled with anti-Pax7 (red), which labels dorsal somitic cells and cells of the dorsal neural tube
(NT). The position of the positive electrode for each electroporation is summarized in the diagram in A. When TOPGFP is directed to the dorsal
region of the somite (B–D), GFP is detected at a later time in the cells of the dermomyotome (DMT). When TOPGFP is directed ventrally (E, F),
GFP expression is not detected in ventral cells that form the presumptive sclerotome (SC). Non-Pax7-expressing cells rarely express TOPGFP. To
demonstrate that lack of sclerotomal expression of TOPGFP is not due to an inability to electroporate the ventral somitic cells, epithelial somites
were electroporated and the control construct, pCAX/GFP, directed to ventral cells. In these experiments, sclerotomal cells readily express GFP
under the direction of the b-actin promoter (G, H). As a negative control, co-electroporations were performed into the dorsal somite using the con-
stitutively active construct pDsRED and FOPGFP, which contains mutated TCF binding sites (Ia–Ic). Somitic cells fail to express GFP (Ic) at appre-
ciable levels when electroporated with FOPGFP despite the expression of DsRED throughout the DMT (Ia, Ib). All sections are immunostained
with anti-Pax7 antibody (blue).



























others (Scaal et al., 2004), plasmid
DNA leaks out of the somitocoel im-
mediately after injection. If leaked
DNA floats to the dorsal side of the
somite, transfection of dorsal cells can
occur during a ventral electroporation
as the electric field includes all cells
between the anode and cathode
(Krull, 2004). Therefore, electropora-
tion of plasmids into the ventral
somite sometimes resulted in GFP
expression not only in the cells tar-
geted by electroporation but also
some dorsal cells that were within the
electric field between the anode and
cathode.
To demonstrate that the lack of
TOPGFP expression in ventral
somitic cells was not due to an inabil-
ity to electroporate these cells, we
electroporated the control plasmid
pCAX/GFP, which constitutively
expresses GFP, under the same condi-
tions as TOPGFP. In these electropo-
rations, GFP expression was observed
in the ventral cells (Fig. 2G, H). These
data combined with the nuclear b-cat-
enin staining indicate that all the
cells in the dorsal half of the early
somites are responding to b-catenin-
dependent Wnt signaling. At this
early stage, Wnt-responsive cells in
the somite correspond to Pax7-
expressing cells.
To further demonstrate that dorsal,
Pax7-positive cells, but not ventral
Pax7-negative cells, of the early
somite respond to signaling through
the canonical Wnt pathway, we co-
electroporated TOPGFP and pDsRED,
or pCAX/GFP and pDsRED, into cells
in the ventral half of the somite. When
TOPGFP was co-electroporated with
pDsRED, GFP expression was only
detected in a few dorsal dermomyoto-
mal cells that expressed Pax7, while
DsRED-expressing cells were detected
throughout the ventral sclerotome
(Fig. 3B,a–c). However, when both
control plasmids (pDsRED and pCAX/
GFP) were co-electroporated into ven-
tral cells, both DsRED and GFP were
observed (Fig. 3C, a–c).
As a negative control for TOPGFP
electroporations, FOPGFP and pDsRED
were co-electroporated into the dorsal
somite. FOPGFP contains mutated
TCF binding sites and is expressed at
significantly reduced levels compared
to TOPGFP. FOPGFP and pDsRED
co-electroporations resulted in DsRED-
expressing cells throughout the dermo-
myotome but no significant GFP was
detected (Fig. 3D, a–c).
Wnt Responsiveness Is
Restricted to Dermomyotmal
Cells in Older Somites
We further investigated the differen-
ces in the Wnt responsiveness of cells
in the dermomyotome and myotome
that we observed in later somites
based on b-catenin nuclear localiza-
tion. TOPGFP and pDsRED or pCAX/
GFP and pDsRED were co-electopo-
rated into the dorsomedial quadrant
of somites and the embryos were
examined 24 hr post-electroporation
for GFP expression. To identify the
different compartments of the somite,
sections of the electroporated embryos
were immunostained with either
Pax7 or MF20 antibodies to identify
the dermomyotome and myotome,
respectively.
Co-electroporation of TOPGFP and
pDsRED resulted in strong co-expres-
sion of both GFP and DsRED in the
DML of the dermomyotome (Fig. 4B,
a–c and 4C, a–c). However, GFP
expression was reduced in dermomyo-
tomal cells outside the DML while
DsRED expression was qualitatively
equal in all dermomyotomal cells
(Fig. 4B, a–c and 4C, a–c). When
pCAX/GFP and pDsRED were co-elec-
troporated (Fig. 4), we rarely
observed cells that only expressed one
of the plasmids without the other;
therefore, while it cannot be com-
pletely eliminated as a possibility, it is
unlikely that the difference in expres-
sion is the result of the plasmids seg-
regating during co-electroporation.
This argues that cells that express
only DsRED after co-electroporation
of pDsRED and TOPGFP are not Wnt
responsive. This is supported by the
co-electroporation of the control plas-
mids pCAX/GFP and pDsRED that
resulted in equivalent intensities of
both GFP and DsRED in the DML
and dermomyotome (Fig. 4Ea–f).
Our earlier data indicated that
myotomal cells do not contain nuclear
b-catenin and suggested that cells in
the myotome do not respond to signal-
ing through the canonical Wnt path-
way. To further examine this unex-
pected result, pDsRED and TOPGFP
DNA was co-electroporated into the
dorsal half of the somite and embryos
were examined 24 hr later. Embryo
sections were immunolabeled with
MF20, an anti-myosin antibody, to
differentiate myotomal cells from
the overlying dermomyotome. We
detected DsRED-expressing, but not
GFP-expressing, cells in the myotome
(Fig. 4C, a–c, arrows). In contrast, an
approximately equivalent number of
GFP-positive cells was observed in
the myotome after electroporation of
pCAX or DNTCF-pMES (see Fig. 8E).
When the negative control plasmid
FOPGFP was tested in co-electropora-
tions of FOPGFP and pDsRED at this
later stage, DsRED was strongly
expressed, whereas only low levels of
GFP were detected in the somite (Fig.
4F, a–c). The lack of significant GFP
expression in the dorsal somite after
electroporation of FOPGFP indicates
that the expression of TOPGFP in
somitic cells is dependent on a func-
tional TCF binding site as well as nu-
clear b-catenin. In addition, in these
experiments examining older somites
as in earlier experiments with
younger somites, only cells that
expressed Pax7 appeared to be
responding to signals through the ca-
nonical Wnt pathway.
Wnt Responsiveness Is
Highest in the DML
To ascertain if there were, indeed, re-
gional differences in the number of
cells that demonstrate Wnt respon-
siveness in the somite, the number of
cells expressing TOPGFP was com-
pared to the number of DsRED-
expressing cells after co-electropora-
tion. The dorsal half of somites II–IV
at HH stages 13–14 was electropo-
rated with TOPGFP and pDsRED
and embryos examined 24 hr later. To
count the percentage of GFP-express-
ing electroporated cells in different
regions of the somite, embryos were
embedded and vibratome sectioned
and the dermomyotome was sub-di-
vided into regions 1–3 and the myo-
tome was designated region 4 (Fig. 5).
Cells that expressed GFP and/or
DsRED were counted in each region.
The percentage of Wnt-responsive













cells is the percentage of DsRed-posi-
tive cells that also expressed GFP. As
previously indicated (Fig. 4B, a–c and
4C, a–c), nearly 100% of the DsRed-
expressing cells in the dorsal DML
(region 2) of the dermomyotome also
expressed GFP, while approximately
half the cells that expressed DsRED
also expressed GFP in regions outside
the dorsal DML (regions 1 and 3; Fig.
5). In contrast to the dermomyotome
where GFP expression was observed
in cells of all three regions, no GFP-
positive cells were detected in the
myotome (region 4; Fig. 5). That
nearly 100% of the cells that express
DsRED also expressed GFP in the
DML of the dermomyotome (region 2;
Fig. 5) suggests that this region rep-
resents a population of highly respon-
sive cells to b-catenin-mediated Wnt
signaling. The cells in the DML repre-
sent a pool of progenitor cells for both
the myotome and dermomyotome
Fig. 3. Sclerotomal cells do not respond to signals through the canonical-Wnt pathway. To
demonstrate that the inability of sclerotomal cells (SC) to express the reporter TOPGFP is not
due to inefficient electroporation, early somites (stage IV–VI) were co-electroporated with
TOPGFP and the control construct, pDsRED (which should be expressed in all cells), and exam-
ined later for GFP and DsRED expression. Electrodes were positioned as illustrated in the dia-
gram in A. In co-electroporations of TOPGFP with pDsRED (Ba–c) into the ventral half of the
somite, DsRED is expressed in both the ventral (SC) and dorsal somitic cells (DMT), but GFP is
only expressed in dorsal cells (DMT). In contrast, when the GFP expression construct, pCAX/
GFP, was co-electroporated with pDsRED into the ventral domain, both GFP and DsRED are
expressed in ventral sclerotomal cells (Ca–c). As a negative control, co-electroporations were
performed into the dorsal somite (shown as position D in the cartoon in A) using FOPGFP, which
contains mutated TCF-binding sites, together with the constitutively expressed construct
pDsRED (Da–c). Somitic cells fail to express GFP (Dc) at appreciable levels when electroporated
with FOPGFP but express DsRED throughout the DMT (Da,b). All sections are immunostained
with anti-Pax7 antibody (blue).
Fig. 4. Wnt-responsive cells are concen-
trated in the DML as the primary myotome
forms. To identify Wnt-responsive cells in
older somites (stages X and older), TOPGFP
and control constructs were co-electroporated
into epithelial somites (the placement of elec-
trodes for each set of electroporations is sum-
marized in the cartoon in A), and examined
after somites had compartmentalized into a
dermomyotome (DMT) and myotome (MYO).
Sections were immunolabeled for either Pax7
(blue) to identify the DMT (B, D, F) or MF20
(blue) to identify cells in the MYO (C, E).
When pDsRED and TOPGFP were targeted to
the dorsomedial aspect of the early somite,
both DsRED and GFP are detected later in
the DMT and dorsomedial lip (DML; B), but
cells expressing GFP were not detected in the
MYO. The arrow in Bb points to a presump-
tive myotomal cell outside the Pax7-positive
region that expresses only DsRED. The arrow
in Cb points to an MF20-positive myotomal
cell that co-expresses DsRED but not GFP.
When somites are co-electroporated with the
control constructs, pCAX/GFP and pDsRED,
cells throughout the later somite co-express
both GFP and DsRED (Da–c, arrows, Ea–f).
When co-electroporated ventrally (Da–c), scle-
rotomal cells (SC) as well as cells in the DMT
and MYO (arrow in Db) co-express DsRED
and GFP. When pCAX/GFP and pDsRED are
co-electroporated dorsally, cells in both the
DMT and MYO co-express GFP and DsRED
(arrows in Ee; Ed–f are enlargements of the
boxed areas in Ea–c, respectively). When
FOPGFP and pDsRED were co-electroporated
as a negative control (electrode position F in
the cartoon in A), DsRED expression is strong
throughout the DMT, but no appreciable GFP
expression is detected.















Fig. 5. b-catenin-dependent Wnt-responsive
cells are enriched in the DML and are not
detected in the myotome. After co-electropo-
ration of TOPGFP and pDsRED, the number
of GFP- and DsRED-positive cells were
counted in transverse sections of somites. Dif-
ferent regions of the somite were designated
as shown in the cartoon. DsRED-positive cells
represent all cells electroporated and GFP-
positive cells represent the subset of electro-
porated cells in which the b-catenin/Wnt-de-
pendent reporter TOPGFP was activated.
Nearly all cells in the DML (region 2) express
both DsRED and GFP. In other regions of the
dermomyotome (regions 1 and 3), approxi-
mately 50% of cells that express DsRED also
express GFP. In the myotome (region 4), how-
ever, no GFP expression was observed. The
number of cells counted in each region was
265 (region 1), 120 (region 2), 63 (region 3),
and 66 (region 4), respectively.













(Venters and Ordahl, 2002; Venters
and Ordahl, 2005). The reduced num-
ber of cells expressing GFP in regions
1 and 3 of the dermomyotome sug-
gests that the progeny of the DML
cells have a reduced response to b-cat-
enin/Wnt signaling. Of particular
note is that once cells are in the myo-
tome and begin to differentiate, they





Because our data suggest that cells in
the myotome do not respond to signal-
ing through the canonical Wnt path-
way, we reasoned that activation of b-
catenin/Wnt signaling in dermomyoto-
mal cells might prevent cells from
entering the myotome. Our b-catenin
immunostaining and TOPGFP data
suggest that there is a reduced
response in cells derived from the
DML. We, therefore, examined the
effect of constitutively activating the
downstream targets of Wnt signaling
in DML cells and determine how this
affected their progeny. To determine
the effect of constitutively activating or
repressing b-catenin/Wnt target genes,
we electroporated constructs into the
dorsal medial quadrant that expressed
GFP constitutively with either a domi-
nant-negative or a dominant-positive
form of TCF1 (DNTCF-pMES and
DPTCF-pMES, respectively), or with
the control pCAX/GFP construct.
Before electroporating DNTCF-
pMES and DPTCF-pMES into somitic
cells, we tested their efficacy in cell
culture and in somite electroporations.
We transfected either DNTCF-pMES
or a construct encoding Wnt1, pWnt1,
together with the LEF1/TCF1-respon-
sive luciferase reporter, TOPflash, into
HEK 293 cells. Transfection of HEK
293 cells with either pWnt1 or
DPTCF-pMES resulted in comparably
high levels of luciferase activity (Fig.
6). Although pWnt1 and DPTCF-
pMES each activated TOPflash signifi-
cantly, neither activated the control
reporter, FOPFlash (Fig. 6). Co-trans-
fection of DNTCF-pMES together with
pWnt1, however, reduced TOPflash
activity to FOPFlash levels (Fig. 6).
These results indicate that DNTCF-
pMES can inhibit the expression of
Wnt target genes that are activated
through the canonical b-catenin-de-
pendent Wnt signaling. In the absence
of any Wnt perturbation, TOPflash ac-
tivity was negligible (Fig. 6). These
results indicate that the modified
forms of TCF we have engineered
should activate or inhibit the expres-
sion of Wnt target genes when ectopi-
cally expressed in vivo.
Previous studies demonstrated that
ectopic expression of RCAS-Wnt1-
and RCAS-activated b-catenin both
resulted in expansion of the Wnt11
expression domain in the chick der-
momyotome (Capdevila et al., 1998),
supporting the role of the canonical
Wnt pathway in the activation of Wnt
11 expression in the DML. In agree-
ment with previous studies (Marcelle
et al., 1997; Capdevila et al., 1998),
we show that Wnt 11 transcript
expression is restricted to the DML of
the dermomyotome (Fig. 7A, B). We,
therefore, tested whether electropora-
tion of DPTCF-pMES or DNTCF-
pMES into the somite influenced the
expression of Wnt 11. We examined
embryos for Wnt 11 expression by in
situ hybridization 24 hr after electro-
poration of DPTCF-pMES, DNTCF-
pMES, or pCAX/GFP into the early
somite. When DNTCF-pMES DNA
was electroporated into the dorsal
somite, significantly reduced expres-
sion of Wnt 11 was observed in dorsal
cells on the electroporated side (Fig.
7D) compared to non-electroporated
somites (Fig. 7A, B) or embryos elec-
troporated with pCAX/GFP (Fig. 7C).
When DPTCF-pMES DNA was elec-
troporated into the ventral somite,
Wnt 11 expression was detected in
ventral regions of the somite (Fig. 7E;
note this is a lateral view). Although
Capdevila et al. (1998) demonstrated
that ectopic expression of RCAS acti-
vated b-catenin and RCAS Wnt-1 also
resulted in expansion of Wnt 11
expression in the dermomyotome, it is
unclear whether different dermomy-
tomal regions respond differently to
activation of the b-catenin-dependent
Wnt signaling pathway.
The above data argue that electro-
poration of DNTCF-pMES and
DPTCF-pMES into somites should
constitutively repress or activate tar-
gets of the canonical Wnt pathway,
respectively, and can be used to mod-
ify the response of somitic cells to
external signals. To further examine
how b-catenin-mediated Wnt signal-
ing influences myotome formation,
somites VII–X were examined follow-
ing electroporation of DNTCF-pMES
or DPTCF-pMES DNA at HH stages
13–14. In somite electroporation
experiments, the DML cells were spe-
cifically targeted by electroporation
and, in contrast to the TOPGFP elec-
troporations, GFP expression after
electroporation of DPTCF-pMES or
DNTCF-pMES is indicative not only
of the cells that were electroporated,
but also the expression of the domi-
nant-negative or dominant-positive
forms of the TCF protein in the elec-
troporated cells. The pMES plasmid
contains the b-actin promoter and an
IRES to allow co-expression of GFP
and modified TCF proteins constitu-
tively and simultaneously in electro-
porated cells (Swartz et al., 2001).
After electroporation of DNTCF-
pMES or pCAX/GFP, GFP-positive
cells were detected in the myotome as
demonstrated by the co-expression of
GFP and MF20 (Fig. 8B and 8C). In
contrast, when DPTCF-pMES was
electroporated, many GFP-positive
cells were detected in the dermomyo-
tome adjacent to the myotome, but
not in the myotome (Fig. 8D). The
number of GFP-positive cells in the
dermomyotome and the myotome
were determined after electroporation
Fig. 6. Modified forms of TCF effectively al-
ter Wnt activity in transfected HEK293 cells.
When either Wnt1 or DPTCF and the Wnt-re-
sponsive reporter TOPflash are transfected
into cells in vitro, both DNAs activated TOP-
flash to comparable levels. In contrast, if
Wnt1 or DPTCF are transfected together with
the modified reporter FOPflash, very low lev-
els of luciferase activity were detected. When
Wnt1 is co-transfected with DNTCF, luciferase
levels were equivalent to those obtained by
Wnt1 activation of FOPFlash. Similarly, when
pCAX/GFP is transfected with TOPflash, basal
levels of luciferase activity were detected.













of each plasmid. Electroporation of
DPTCF-pMES resulted in 100% of the
electroporated (GFP-positive) cells in
the dermomyotome and no GFP-posi-
tive cells in the myotome (Fig. 8E). In
contrast, after electroporation of
pCAX/GFP or DNTCF-pMES, an
approximately equivalent number of
GFP-positive cells was observed in
the myotome (Fig. 8E).
DISCUSSION
It previously was proposed that sig-
naling through the canonical Wnt
Fig. 7. Wnt11 expression in somites is altered after electroporation of DNTCF-pMES or DPTCF-pMES. In a non-electroporated embryo, Wnt11 is
expressed in the DML in somites on both sides of the neural tube (A). A transverse section of the non-electroporated embryo shown in A (at the
level of the dotted line) shows Wnt11 expression was highest in the DML of the somite (B). After electroporation of pCAX/GFP (C), Wnt11 expres-
sion was similar to that observed in a non-electroporated embryo. Wnt11 expression was greatly diminished in those somites where DNTCF-
pMES was electroporated (D, arrowheads), while Wnt11 expression was observed in the DMLs of all the somites on the contralateral side of the
embryo. Following electroporation of DPTCF-pMES, Wnt11 is expressed ectopically in the ventral somite (E, arrowheads) as shown in a lateral
view of the DPTCF electroporated embryo.
Fig. 8.
Fig. 8. Effects of constitutively activating or
repressing Wnt activity on DML progeny. To
investigate the consequences of activating or
repressing signaling through the canonical
Wnt pathway in DML cells, DNTCF-pMES and
DPTCF-pMES were targeted to the DML of
stage-VII–X somites and the number of GFP-
positive cells in the myotome were counted
after 24 hr. Electrodes were positioned as
illustrated in the cartoon in A and sections
stained with MF20 to identify cells in the myo-
tome (MYO). Electroporation of both pCAX/
GFP (B) and DNTCF-pMES (C) resulted in
GFP-positive cells in both the DMT and MYO
(arrows in B, C). After electroporation of
DPTCF-pMES, GFP-positive cells were
detected in the DMT, but not in the MYO (D).
The mean number of GFP-expressing cells in
the DMT (green) versus the MYO (yellow) for
each construct electroporated is shown in E.













pathway plays a proliferative role in
the somite (Galli et al., 2004), but it
was not known if all or a subpopula-
tion of somitic cells were Wnt respon-
sive or when during somitogenesis or
myogenesis they respond. We show
that b-catenin/Wnt-responsive cells
can be detected throughout the early
dermomyotome and while cells in the
dermomyotome of older somites main-
tain a degree of responsiveness, the
greatest response is observed in the
cells of the DML. Wnt-responsive cells
in both the early and compartmental-
ized somite also expressed Pax7 (Figs.
2–4). In later somites, the b-catenin/
Wnt-responsive cells are enriched in
the DML of the dermomyotome, and
these cells have been shown to co-
express Pax7 and Pax3 (Galli et al.,
2008). While some studies have
reported that ectopic expression of
Pax7 promotes withdrawal from the
cell cycle (Olguin and Olwin, 2004),
others have found that ectopic expres-
sion of Pax7 maintains proliferation
and prevents the precocious differen-
tiation of myoblasts (Zammit et al.,
2006). Other recent studies show that
Pax3 and Pax7 expression in the
somite is inversely correlated with
that of MyoD, and that Pax7 expres-
sion positively correlates with prolif-
eration and negatively correlates with
myogenic differentiation (Galli et al.,
2008). These data combined with our
results argue that b-catenin-mediated
Wnt signaling acts to maintain cells
in the DML of the dermomyotome in a
proliferative and undifferentiated
state. However, it remains to be deter-
mined whether b-catenin/Wnt signal-
ing is directly responsible for the
maintenance of Pax3 or Pax7 expres-
sion in cells of the DML.
Using multiple strategies, we found
that myotomal cells no longer respond
to signaling via the canonical Wnt
pathway. When cells are in the myo-
tome, they no longer contain nuclear
b-catenin or transcriptionally activate
the b-catenin-dependent responsive
reporter TOPGFP despite close prox-
imity to the dorsal neural tube, a
major source of Wnt signals. Because
it is thought that b-catenin-mediated
Wnt signaling is needed for the for-
mation of the myotome and the acti-
vation of myogenic regulatory factors
(Munsterberg and Lassar, 1995; Die-
trich et al., 1997; Schmidt et al.,
2000), lack of b-catenin staining in
the nuclei of myotomal cells and the
absence of TOPGFP expression were
unexpected.
Lack of b-catenin-dependent Wnt
responsiveness in myotomal cells does
not exclude the possibility that the
cells responded to a Wnt signal in their
recent history. However, it does sug-
gest that cells might be required to
cease responding to b-catenin-depend-
ent Wnt signaling in the myotome. To
address this possibility, we electropo-
rated modified forms of the Wnt effec-
tor, TCF, designed to either block or
activate downstream events in the b-
catenin-dependent Wnt signaling
pathway. In these experiments, the
cells expressing the modified TCFs
could be identified by the co-expression
of GFP from the same plasmid. This
allowed determination of the effect of
constitutively activating or repressing
b-catenin-dependent Wnt signaling in
a cell-autonomous manner.
We found that no GFP-expressing
cells were identified in the myotome if
the canonical Wnt pathway was con-
stitutively activated in DML cells by
electroporation of a DNTCF-pMES.
However, comparable numbers of
GFP-expressing cells were found in
the myotome when DML cells were
electroporated with DNTCF-pMES or
the control plasmid, pCAX/GFP. We
observed a decrease in the overall
number of cells expressing GFP in
both the dermomyotome and the myo-
tome following electroporation of
DNTCF-pMES (Fig. 8). This argues
that proliferation in the dorsal somite
is adversely affected by repressing
the ability of cells to respond to b-cat-
enin-mediated Wnt signaling. This is
consistent with the results obtained
following electroporation of Wnt3a
(Galli et al., 2004), which led to an
increase in the number of cells in both
the myotome and dermomyotome.
The shift between myoblast prolif-
eration and differentiation in vitro
has been shown to require stimula-
tion of N-cadherin-mediated adhesion
(George-Weinstein et al., 1997; Cinna-
mon et al., 2006) and that the interac-
tion of b-catenin with cadherins
antagonizes b-catenin and Lef/TCF
interactions (Goichberg and Geiger,
1998; Goichberg et al., 2001). Simi-
larly, nuclear b-catenin is observed in
proliferative myoblasts, but b-catenin
translocates to cell membranes upon
myogenic differentiation (Goichberg
et al., 2001). Conversely, elevation of
b-catenin levels in myogenic cell lines
by LiCl treatment or b-catenin over-
expression reduced intercellular ad-
hesion and inhibited myogenesis
(Goichberg et al., 2001). These studies
support our data suggesting that the
transcriptional role of b-catenin must
be suppressed prior to myoblast dif-
ferentiation. We and others (Linask
et al., 1998) show that a high level of
membrane-associated b-catenin is
found in the myotomal cells in vivo
and despite high levels of b-catenin
protein expression (Fig. 1), no nuclear
b-catenin is detected.
Recent results suggest involvement
of signaling through the non-canoni-
cal Wnt pathway in myotomal cell
specification (Chen et al., 2005; Bru-
nelli et al., 2007). We (Fig. 7) and
others (Marcelle et al., 1997; Capde-
vila et al., 1998) have shown that Wnt
11 is a target of signaling through the
canonical Wnt pathway in the DML.
Our data are consistent with a role
for the canonical Wnt pathway in the
maintenance of the DML myogenic
precursor pool and a role for signaling
through the non-canonical Wnt sig-
naling pathway in their differentia-
tion possibly mediated by Wnt 11. The
non-canonical Wnt pathway has been
shown to inhibit signaling through
the canonical Wnt pathway (Wei-
dinger and Moon, 2003; Veeman
et al., 2003) and could account for the
loss of b-catenin/Wnt responsiveness
in DML cell progeny. Electroporation
of a dominant-negative form of
Wnt5b, another Wnt that acts
through the non-canonical pathway,
resulted in the loss of MyoD expres-
sion in the medial somite (Linker
et al., 2003), and Wnt5b, working
through the non-canonical Wnt path-
way, can lower the cellular response
to canonical Wnt signaling in other
cell types (Kanazawa et al., 2005).
Thus, the reduced response of cells in
the medial somite to canonical Wnt
signaling may be through activation
of Wnt5b. Although dorsal signaling
through the canonical Wnt pathway
may not be needed for the initial
expression of MyoD in the medial
somite, it is needed for the continued
expression of MyoD. If all dorsal Wnt-
expressing tissue is removed, MyoD













expression is lost within 24 hr (Pow-
nall et al., 1996; Dietrich et al., 1997).
One possible explanation is that Wnts
working through the canonical path-
way are needed to induce or maintain
the expression of Wnts working
through the non-canonical Wnt path-
way. Further analysis of Wnt 5b and
Wnt 11 function specifically in the
DML cells is needed to reconcile the
roles for canonical versus non-canoni-
cal Wnt pathways in vivo.
Our data support the proposed
model that the DML is a stem cell
center (Venters and Ordahl, 2002;
Venters and Ordahl, 2005) and sug-
gest that signaling through the ca-
nonical pathway acts to maintain
cells in the DML as progenitor cells.
It is also consistent with the role of
signaling through the canonical Wnt
pathway in the adult muscle stem
cell, the satellite cell. Satellite cells
express b-catenin as the cells acti-
vate and undergo proliferation and
constitutive expression of wild type
or stabilized b-catenin promotes a
self-renewal pathway, while down-
regulation of b-catenin promotes
myogenic differentiation (Perez-Ruiz
et al., 2008). Thus, b-catenin-depend-
ent signaling in proliferating satel-
lite cells directs these cells towards
the self-renewal pathway and main-
tains this stem-cell pool in adult
skeletal muscle. The canonical Wnt
pathway may, therefore, function to
control the self-renewal of stem cells
in the DML whose progeny contrib-




Chicken Eggs and Embryo
Preparation
Fertilized White Leghorn chicken
eggs were obtained from Ideal Poultry
(Cameron, TX) or Hy-Line North
America, LLC (Elizabethtown, PA)
and incubated at 38C in a humidified
incubator until needed (G.Q.F, Sa-
vanna, GA). For electroporation,
embryos were incubated until they
reached HH stages 13–14 (Ham-
burger and Hamilton, 1992). After
electroporation, embryos were re-
incubated for specific times as
described below, then fixed and proc-
essed. Embryos were dissected from
the eggs and placed in Ringer’s solu-
tion. Before fixation they were
washed 3 times for 10 min each in





embryos were fixed in 4% parafor-
maldehyde (PFA) in phosphate buf-
fered saline (PBS) overnight (O/N) at
4C on a rotating shaker. After fixa-
tion, embryos were washed three
times in PBS for 5 min. Fixed
embryos were dehydrated through a
graded alcohol series followed by two
changes of xylene for 30 min each at
RT. Embryos were incubated in fresh
paraffin at 56C for 2 times 1 hr
each. Embryos were embedded in
paraffin and oriented to yield trans-
verse sections. A standard microtome
was used to cut 5-lm transverse sec-
tions. Sections were mounted on
slides and deparaffinized using 2
changes of xylene for 5 min each, re-
hydrated through a graded alcohol
series and washed 2 times for 5 min
in PBS. Sections were placed in a
chamber containing 10 mM sodium
citrate buffer (pH 6), 0.1% Tween 20
(Sigma, St. Louis, MO), and treated
30 min in a 2100 Retriever (Pick
Cell Laboratories, Amsterdam, The
Netherlands) and allowed to incu-
bate for an additional 2 hr for anti-
gen retrieval. All subsequent steps
were carried out in a humidified
slide chamber. Propidium iodide (PI)
was used to stain nuclei, but first
sections were incubated in a solution
of 10 lg/ll RNaseA (Sigma, St.
Louis, MO) in PBS for 30 min at
37C to eliminate cytoplasmic RNA.
After RNase treatment, sections
were washed 3 times for 5 min in
PBS, and blocked in 4% normal goat
serum (NGS) in PBS with 0.1%
Tween 20 (PBST) for 30 min. Sec-
tions were incubated in monoclonal
anti-b-catenin antibody (Transduc-
tion Labs, San Jose, CA; 250 lg/ml)
at 1:100 dilution in PBST for 1 hr at
37C. Sections were washed 3 times
for 5 min in PBS and then incubated
for 1 hr at RT in secondary antibody
and 1 mg/ml PI was diluted 1:1,000
in PBST. Sections were incubated in
goat anti-mouse Alexa Fluor 488 con-
jugated secondary antibody (2 mg/
ml) diluted 1/500 in PBST for 1 hr at
RT and the sections were then
washed an additional 3 times in PBS
and mounted with Pro-long Antifade
Gold (Molecular Probes, Eugene,
OR). Images were obtained using a
Zeiss MrC5 Axiocam digital camera
attached to a Zeiss Axioskop2 fluo-
rescence microscope (Carl Zeiss, Inc.,
Thuringia, Germany).
Electroporation
In ovo electroporation was used for
focused introduction of various DNAs
into developing chicken somites at
HH stages 13–14 (Scaal et al., 2004).
To enhance contrast and visualize the
embryo, a solution of 3% India ink
(Pelikan, Germany) diluted in Ring-
er’s solution was injected below the
blastoderm and the vitelline mem-
brane overlying the embryo was
removed. Plasmids were ethanol pre-
cipitated and resuspended to 5–7 lg/
ll in sterile PBS. For two plasmid
electroporations, single plasmids
were mixed so that the final concen-
tration of each plasmid was 5–7 lg/ll
in sterile PBS. DNA was prepared for
injection by mixing 4.75 ll of single or
double plasmid DNA with 0.25 ll of
20% Fast Green (Sigma, St. Louis,
MO) in sterile PBS. In all cases, DNA
was microinjected into the somitocoel
using an MPPI-2 Pressure Injector
(Applied Scientific Instrumentation,
Inc., Eugene, OR) so that all injec-
tions introduced comparable amounts
of DNA. Each somite received approx-
imately 0.15 ll of DNA for a total
quantity of 0.9 lg of DNA/somite for
single plasmid injections and 1.8 lg of
DNA/somite for double plasmid injec-
tions. Following electroporation, ap-
proximately 0.5 ml of Ringer’s solu-
tion was placed on top of the embryo.
Electrode position was used to target
individual quadrants of the epithelial
somite during electroporation, as
defined by the cells’ orientation rela-
tive to the neural tube (Scaal et al.,
2004). The anode and the cathode
were oriented so that the targeted
quadrant was adjacent to the anode
(Scaal et al., 2004). In all cases, the













anode was placed approximately 180
opposite to the cathode. Routinely, 5
pulses of 50-ms duration and 9–15 V
were delivered using two 1-mm plati-
num wires connected to a square
pulse electroporator (BTX, San Diego,
CA). Electroporations were performed
with the control plasmid pCAX/GFP,
which constitutively expresses GFP
from the chicken b-actin promoter/
CMV-IE enhancer (Swartz et al.,
2001; Osumi and Inoue, 2001) to
determine the best placement of elec-
trodes for expression in individual
quadrants and the amount of injected
DNA that could be tolerated without
causing morphological damage. All
electroporations were performed on
one side and transverse sections of
fixed and sectioned embryos were
stained with Pax7, so that the electro-
porated side could be compared to the
non-electroporated side and only
embryos demonstrating comparable
morphology and levels of protein
expression on each side were used for
further analyses. Successful electro-
porations targeted a subset of cells
adjacent to the positive electrode and
were identified by the expression of
the respective fluorescent proteins.
To examine endogenous Wnt activ-
ity in the somite, one or a combination
of the following plasmids was electro-
porated: TOPGFP, FOPGFP, pCAX/
GFP, or pDsRED. DNA was electropo-
rated into the dorsal medial, dorsal
lateral, ventral medial, and ventral
lateral quadrants of epithelial
somites. To obtain somites at two dif-
ferent stages of myotome formation,
somites were examined at either 6
or 24 hr post-electroporation. Somites
II–IV of HH stages 13–14 were injected
with single or multiple plasmids,
followed by targeted electroporation.
Plasmids Electroporated
TOPGFP, consisting of 4 consensus
TCF/LEF binding sites and a minimal
94-bp promoter derived from the
mouse cFos gene driving destabilized
GFP (Dorsky et al., 2002), was elec-
troporated as described above to iden-
tify Wnt-responsive cells in different
regions of developing somites.
FOPGFP consisting of 6 mutated
TCF/Lef binding sites upstream of
GFP (from A. Munsterberg, Univer-
sity of East Anglia, Norwich, UK) was
used as a negative control. FOPGFP
was generated by cloning an XbaI
fragment containing the mutated
TCF/Lef binding sites from FOPFlash
and inserting this into NseI and XhoI
digested pEGFP.N3 (Clontech, Moun-
tainview, CA). Either pDsRED (Clon-
tech, Mountainview, CA) expressing
DsRED under the control of a CMV
viral promoter or pCAX/GFP, which
expresses GFP under direction of a
chicken b-actin promoter/CMV-IE
enhancer (Swartz et al., 2001), was
used as an indicator of all electropo-
rated cells since they should be




pMES) TCFs were constructed using
modified forms of a mouse/human
TCF-1 cDNA (from H. Clevers, Uni-
versity of Utrecht, The Netherlands),
mhTCF-1 in pcDNA1 (van de Weter-
ing et al., 1996). For DNTCF, the
sequence encoding the b-catenin-
binding domain of mhTCF-1 (amino
acids 1–56) was removed to generate
a TCF protein that cannot interact
with b-catenin, DNTCF-1 in pcDNA1.
DNTCF-1 cDNA was excised with
HindIII and XbaI, filled in, and
ligated into SmaI-digested pMES. For
DPTCF, the b-catenin-binding domain
of mhTCF-1 was replaced with the
activation domain of b-catenin (amino
acids 652–781) to generate a protein
that is constitutively active (Aoki
et al., 1999), DPTCF-1 in pcDNA1.
Coding sequence of DPTCF-1 was
excised with BamHI and XbaI, filled
in, and ligated into the SmaI site of
pMES. The pMES expression plasmid
(Swartz et al., 2001) contains an
IRES-EGFP sequence that allows
reliable co-expression of EGFP and
the protein of interest. All constructs
were sequenced to assure that the
DNA was inserted in frame. The
expression of ectopic DNTCF and
DPTCF-1 protein was verified by im-
munostaining sections of electropo-
rated somites with antibody to human
TCF-1 (Santa Cruz Biotechnology,
Santa Cruz, CA). Expression of
DNTCF-1 or DPTCF-1 proteins was
observed only in the nuclei of somitic
cells co-expressing GFP (data not
shown) after electroporation of
DNTCF-pMES or DPTCF-pMES.
In Vitro Transfections
The Wnt reporter construct TOPflash
(Upstate, Charlottesville, VA), con-
taining 6 TCF/Lef binding sites
upstream of the Luciferase gene was
used as a measure of the functional
efficacy of the DNTCF-pMES and
DPTCF-pMESDNAs. FOPflash (Upstate),
which contains 6 mutated TCF bind-
ing sites upstream of luciferase, was
used as a negative control. Wnt1 in
pCDNA3 (Nam et al., 2006) and LacZ
in pCDNA3 (from Drs. J.K. Yoon and
J. M. Verdi, respectively, MMCRI,
Scarborough, ME) were transfected
together with either DNTCF-pMES
orDPTCF-pMES DNAs into human
embryonic kidney 293 (HEK293) cells.
HEK293 cells were plated (at 60,000
cells/well) into Costar 12-well plates
(Corning, Acton, MA). Cells were
incubated at 37C in 5% CO2 for an
additional 24 hr and then transfected
using GeneJuice Transfection Rea-
gent (Novagen, San Diego, CA) at
1.5 ll of GeneJuice Transfection
Reagent containing 0.5 lg of total
DNA. For each transfection, 100 ng of
reporter construct, 200 ng of the indi-
cated expression plasmid, and 20 ng
of pRL-TK normalization plasmid,
containing a herpes simplex virus
thymidine kinase promoter driving a
Renilla luciferase gene, were used per
single well of a 12-well plate. Empty
pCS2-LacZ vector was used to adjust
the total amount of DNA to 500 ng.
Transfection experiments were per-
formed in duplicate, and results were
normalized to the expression of the
Renilla luciferase transfection control
(Promega, Madison, WI). The cells
were lysed in Promega Passive Lysis
Buffer, and 20 ll of each lysate was
monitored for luciferase activity using
a Dual-Luciferase Reporter Assay System
(Promega, Madison, WI). Light units
were measured using a Zylux FB12
Luminometer (Oak Ridge, TN) set for
1-sec delay and 1-sec reading.
Visualization of Structures
Following Electroporation
Electroporated embryos were fixed as
described above for immunofluores-
cent labeling and embedded in 7.5%
Gene Pure low-melting agarose (ISC
Bioexpress, Kaysville, UT). Embryos













were oriented in the agarose to obtain
transverse sections. Embryos were
sectioned at 100-lm thickness using a
Leica VT1000s Vibratome (Leica
Microsystems, Germany). After vibra-
tome sectioning, sections were perme-
ablized with 0.5% Triton X 100
(Sigma) in PBS for 15 min. Sections
were blocked for 30 min in PBS with
0.1% Tween-20 (PBST; Bio-Rad, Her-
cules, CA) and 4% normal goat serum
(NGS; Invitrogen, Carlsbad, CA).
To determine which cells in somites
express reporters after electropora-
tion, embryo sections were stained
with antibodies to the transcription
factor, Pax7, to label dorsal somitic
cells (Chi and Epstein, 2002) or to my-
osin heavy chain (MF20) to visualize
myotomal cells. The Pax7 antibody
was used at a 1:50 dilution and the
MF20 antibody was used at 1:100.
Both monoclonal antibodies were
obtained from the Developmental
Studies Hybridoma Bank (under the
auspices of the NICHD, and main-
tained by the University of Iowa,
Department of Biological Sciences,
Iowa City, IA 52242). Alexa Fluor 405,
488, or 568 anti-mouse secondary anti-
bodies (Molecular Probes; 2 mg/ml)
were applied at 1:500 in PBST de-
pending on which plasmids were
electroporated.
Sections were incubated overnight
in primary antibodies at 4C on a
shaker. Sections were incubated at
RT in the appropriate secondary anti-
body for 1 hr on a shaker. Sections
were washed again as described above
with PBST and mounted in Prolong
Gold mounting media (Molecular
Probes).
Confocal Microscopy
Electroporated embryos were initially
assessed on a Zeiss StemiSv6 fluores-
cent dissecting microscope to deter-
mine the success of electroporation.
After fixation, sectioning, and/or
immunolabeling where appropriate,
the stained embryo sections were
imaged using a Bio-Rad Radiance
2000 Confocal Microscope. Each chan-
nel was imaged sequentially to ensure
that signal was not due to cross-exci-
tation of wavelengths. Images were
processed using Adobe Photoshop 7.0.
Quantification of
Electroporated Cells
To count the number of cells respond-
ing to Wnt signaling during myotome
formation in different parts of the
somite, embryos (n¼19) were electro-
porated with TOPGFP and pDsRED,
incubated 24 hr, then fixed, sectioned,
and imaged as previously described.
Cells were counted in the following
regions: (1) the dermomyotome, the
lateral-most epithelial layer; (2) dor-
sal DML, those cells of the dermomyo-
tome, as seen in cross-section, that
primarily demonstrate a dorsal-to-
ventral orientation; (3) ventral DML,
the medial-most cells of the DML that
primarily demonstrate a medial-to-
lateral orientation; and (4) the myo-
tome, those cells that lie beneath both
the dermomyotome and the ventral
DML (Fig. 5). A comparable method
previously was used to classify cells of
the dermomyotome (Venters and
Ordahl, 2005). Cells were counted
twice, once with only the green chan-
nel visible and once with only the red
channel visible. Cell counts were
tallied for each region in each of the
two channels. Binomial confidence
values were calculated using Micro-
soft Excel X.
In Situ Hybridization
In situ probes were generated from a
1-kb chicken Wnt11 clone encompass-
ing the entire coding region (Marcelle
et al., 1997). DNAwas linearized with
SalI (New England Biolabs, Ipswich,
MA) and sense cRNA was in vitro
transcribed using the Sp6 Megascript
Kit (Ambion, Austin, TX ) and digoxi-
genin-11-UTP (Roche, Germany)
according to the manufacturer’s pro-
tocol. Following electoroporation of ei-
ther DPTCF-pMES or DNTCF-pMES,
embryos for which GFP expression
was detected in the appropriate
region of the somite were chosen for
further analysis by whole mount in
situ hybridization. The embryos were
processed for in situ hybridization as
described by Nieto et al. (1996). The
embryos were incubated in antisense
probe (1 lg/ml in hybridization buffer)
for 1 hr at 70C. Alkaline phosphatase
conjugated anti-digoxigenin antibody
(Roche, Indianapolis, IN) used was at
1:2,000 dilution in Tris-buffered sa-
line with 1.5% blocking powder
(Roche, Indianapolis, IN). The
embryos were incubated for 2 hr in
BM purple substrate solution (Roche,
Indianapolis, IN) at RT. Images were
obtained using a Zeiss MrC5 Axiocam
digital camera attached to a Zeiss Ste-
miSv6 stereoscope.
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